SCHEMBL28069730

SCHEMBL28069730

CCS(=O)(=O)OC1(C)CCC(O)(C(F)(F)F)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28171249 0.80
SCHEMBL28069663 0.78
SCHEMBL28330506 0.73
SCHEMBL19028077 0.73 NPSR1 (0.30)
SCHEMBL27142936 0.71
SCHEMBL28412137 0.71
SCHEMBL28069728 0.71 HSD11B1 (0.34)
SCHEMBL25519651 0.69
SCHEMBL28363056 0.68
SCHEMBL17682209 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111233863-B Hydroxyl purine compound and application thereof 广东众生睿创生物科技有限公司 2022-10-25 CN disclosed
CN-108348525-B Medical application of hydroxyl purine compound 广东众生睿创生物科技有限公司 2021-09-10 CN disclosed
CN-111233863-A Hydroxyl purine compound and application thereof 广东众生睿创生物科技有限公司 2020-06-05 CN disclosed
CN-105566324-B Hydroxyl purine compound and application thereof 广东众生睿创生物科技有限公司 2020-04-03 CN disclosed
CN-107001371-B Oxipurinol class compound and its application 广东众生睿创生物科技有限公司 2019-07-05 CN disclosed
CN-108348525-A The medical usage of oxipurinol class compound 广东众生药业股份有限公司 2018-07-31 CN disclosed
CN-107001371-A Oxipurinol class compound and its application 广东众生药业股份有限公司 2017-08-01 CN disclosed
CN-105566324-A Hydroxyl purine compound and application thereof GOOD DOCTOR PHARMACEUTICAL GROUP CO LTD 2016-05-11 CN disclosed